""	"Rank"	"NCT.Number"	"Title"	"Status"	"Study.Results"	"Conditions"	"Interventions"	"Phases"	"Study.Type"	"Locations"	"URL"
"318"	318	"NCT04413838"	"Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection"	"Not yet recruiting"	"No Results Available"	"Obesity, COVID-19 Infection"	"drug: nivolumab|other: routine standard of care"	"Phase 2"	"Interventional"	"Hôpital Lyon Sud Service Endocrinologie, Diabète et Nutrition, Pierre-Bénite, France"	"https://ClinicalTrials.gov/show/NCT04413838"
"448"	448	"NCT04335305"	"Checkpoint Blockade in COVID-19 Pandemic"	"Recruiting"	"No Results Available"	"COVID-19|Pneumonia, Viral"	"drug: tocilizumab|biological: pembrolizumab (mk-3475)"	"Phase 2"	"Interventional"	"Hospital Quirónsalud Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Ruber Juan Bravo, Madrid, Spain|Hospital Ruber Internacional, Madrid, Spain|Hospital Arnau de Vilanova-Lliria, Valencia, Spain|Hospital Universitario Doctor Peset, Valencia, Spain"	"https://ClinicalTrials.gov/show/NCT04335305"
"597"	597	"NCT04343144"	"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort."	"Not yet recruiting"	"No Results Available"	"COVID19- Infection With SARS-CoV-2 Virus"	"drug: nivolumab injection"	"Phase 2"	"Interventional"	"Pneumologie hôpital Tenon, Paris, France"	"https://ClinicalTrials.gov/show/NCT04343144"
"664"	664	"NCT04356508"	"COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1"	"Not yet recruiting"	"No Results Available"	"COVID-19|SARS-CoV-2|2019-nCoV|Pneumonia, Viral"	"drug: nivolumab"	"Phase 2"	"Interventional"	""	"https://ClinicalTrials.gov/show/NCT04356508"
"719"	719	"NCT04333914"	"Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection"	"Suspended"	"No Results Available"	"SARS-CoV-2 (COVID-19) Infection|Advanced or Metastatic Hematological or Solid Tumor"	"drug: chloroquine analog (gns651)|drug: nivolumab|drug: tocilizumab|other: standard of care|drug: avdoralimab|drug: monalizumab"	"Phase 2"	"Interventional"	"Centre Léon Bérard, Lyon, Rhône, France|CHU Clermont Ferrand, Clermont Ferrand, France|Centre Oscar Lambret, Lille, France|AP-HP Hôpital Saint Antoine, Paris, France|AP-HP La Pitié Salpétrière, Paris, France|Hôpital Saint-Joseph, Paris, France|AP-HP Tenon, Paris, France|AP-HP Hôpital Bichat Claude Bernard, Paris, France|GH Diaconesses Croix Saint Simon, Paris, France|Gustave Roussy, Villejuif, France"	"https://ClinicalTrials.gov/show/NCT04333914"
"877"	877	"NCT04268537"	"Immunoregulatory Therapy for 2019-nCoV"	"Not yet recruiting"	"No Results Available"	"2019 nCoV, PD-1"	"drug: pd-1 blocking antibody+standard treatment|drug: thymosin+standard treatment|other: standard treatment"	"Phase 2"	"Interventional"	""	"https://ClinicalTrials.gov/show/NCT04268537"
